These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17141966)

  • 21. Non-placental causes of intrauterine growth restriction.
    Hendrix N; Berghella V
    Semin Perinatol; 2008 Jun; 32(3):161-5. PubMed ID: 18482615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrauterine growth retardation (IUGR): epidemiology and etiology.
    Romo A; Carceller R; Tobajas J
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():332-6. PubMed ID: 19404231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal smoking exposure and asymmetric fetal growth restriction.
    Delpisheh A; Brabin L; Drummond S; Brabin BJ
    Ann Hum Biol; 2008; 35(6):573-83. PubMed ID: 18932054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GDM women in good glycemic control: which meal-related measure enhances fetal well-being?
    Most O; Langer O
    J Perinat Med; 2007; 35(6):481-5. PubMed ID: 18052834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction.
    Al Nakib M; Desbrière R; Bonello N; Bretelle F; Boubli L; Gabert J; Levy-Mozziconacci A
    Fetal Diagn Ther; 2009; 26(1):24-8. PubMed ID: 19816026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of oxidative stress in intrauterine growth restriction.
    Biri A; Bozkurt N; Turp A; Kavutcu M; Himmetoglu O; Durak I
    Gynecol Obstet Invest; 2007; 64(4):187-92. PubMed ID: 17664879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome.
    Valsamakis G; Kanaka-Gantenbein C; Malamitsi-Puchner A; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():138-47. PubMed ID: 17308140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental IUGR and later diabetes.
    Martin-Gronert MS; Ozanne SE
    J Intern Med; 2007 May; 261(5):437-52. PubMed ID: 17444883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Offspring of diabetic pregnancy: short-term outcomes.
    Michael Weindling A
    Semin Fetal Neonatal Med; 2009 Apr; 14(2):111-8. PubMed ID: 19249005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of glucose control in diabetic pregnancy to fetal cholesterol homeostasis.
    Gordon Y; Patterson TM; Parker CR
    J Matern Fetal Neonatal Med; 2009 Jan; 22(1):8-12. PubMed ID: 19085625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of glycemic control on fetal lung maturity in gestations affected by diabetes or mild hyperglycemia.
    De Luca AK; Nakazawa CY; Azevedo BC; Rudge MV; De Araújo Costa RA; Calderon IM
    Acta Obstet Gynecol Scand; 2009; 88(9):1036-40. PubMed ID: 19636976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrosomia in well controlled CSII treated Type I diabetic pregnancy.
    Cohen O; Keidar N; Simchen M; Weisz B; Dolitsky M; Sivan E
    Gynecol Endocrinol; 2008 Nov; 24(11):611-3. PubMed ID: 19031216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia.
    Clausen TD; Mathiesen ER; Hansen T; Pedersen O; Jensen DM; Lauenborg J; Damm P
    Diabetes Care; 2008 Feb; 31(2):340-6. PubMed ID: 18000174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating the mother--protecting the unborn: the safety of hypoglycemic drugs in pregnancy.
    Klieger C; Pollex E; Koren G
    J Matern Fetal Neonatal Med; 2008 Mar; 21(3):191-6. PubMed ID: 18297574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of insulin glargine during pregnancy: a case-control pilot study.
    Price N; Bartlett C; Gillmer M
    BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infant of diabetic mother: a continuing challenge for perinatal-neonatal medicine.
    Wu PY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):312-9. PubMed ID: 8942023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preaxial hallucal polydactyly as a marker for diabetic embryopathy.
    Adam MP; Hudgins L; Carey JC; Hall BD; Coleman K; Gripp KW; Perez-Aytes A; Graham JM
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):13-9. PubMed ID: 18798547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenerational inheritance of the insulin-resistant phenotype in embryo-transferred intrauterine growth-restricted adult female rat offspring.
    Thamotharan M; Garg M; Oak S; Rogers LM; Pan G; Sangiorgi F; Lee PW; Devaskar SU
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1270-9. PubMed ID: 17213472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perinatal circulating visfatin levels in intrauterine growth restriction.
    Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
    Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.